Abstract
This chapter deals with current topics in valvular heart disease. Focusing on the most common types of diseased valve encountered in routine surgical practice including floppy mitral valves, degenerate tricuspid aortic valves and congenital bicuspid aortic valves. The pathology of infective endocarditis and rheumatic valvular heart disease is also discussed. Macroscopic and microscopic images of the different valve pathologies are provided as well as a detailed description of valve pathophysiology. The scientific data underlying the pathogenesis of the different forms of valvular heart disease is provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Filsoufi F, Carpentier A. Principles of reconstructive surgery in degenerative mitral valve disease. Semin Thorac Cardiovasc Surg. 2007;19:103–10.
Still WJS. Endocardial thickening associated with diseased valves. Br Heart J. 1961;23:155–61.
Coffey S, Harper AR, Cairns BJ, Roberts ISD, Prendergast BD. Clinical information has low sensitivity for postmortem diagnosis of heart valve diseases. Heart. 2017;103:1031–5.
Cherubin CE, Neu HC. Infective endocarditis at the Presbyterian Hospital in New York City. Am J Med. 1971;51:83–95.
Rabinovich S, Evans J, Smith IM, et al. A long-term view of bacterial endocarditis. Ann Intern Med. 1965;63:185–98.
Devereux RB, Frary CJ, Kramer-Fox R, et al. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol. 1994;74:1024–9.
Devereux RB, Brown WT, Kramer-Fox R, et al. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med. 1982;97:826–32.
Clemens JD, Horwitz RI, Jaffe CC, et al. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral valve prolapse. N Engl J Med. 1982;307:776–81.
McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82:681–8.
Hickey AJ, MacMahon SW, Wilcken DEL. Mitral valve prolapse and bacterial endocarditis: when is antibiotic prophylaxis necessary? Am Heart J. 1985;109:421–35.
Danchin N, Voiriot P, Briancon S, et al. Mitral valve prolapse as a risk factor for infective endocarditis. Lancet. 1989;1:743–5.
MacMahon SW, Hickey AJ, Wilcken DE, et al. Risk of infective endocarditis in mitral valve prolapse with and without precordial murmurs. Am J Cardiol. 1987;59:105–8.
Marks AR, Choong CY, Sanfilippo AJ, et al. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med. 1989;320:1031–6.
Varstela E, Verkkala K, Pohjola-Sintonen S, et al. Surgical treatment of infective aortic valve endocarditis. Scand J Thorac Cardiovasc Surg. 1991;25:167–74.
Janatuinen MJ, Vanttinen EA, Nikoskelainen J, et al. Surgical treatment of active native endocarditis. Scand J Thorac Cardiovasc Surg. 1990;24:181–5.
Lamas CC, Ekyn SJ. Bicuspid aortic valve – a silent danger: analysis of 50 cases of infective endocarditis. Clin Infect Dis. 2000;30:336–41.
Moulsdale MT, Eykyn SJ, Phillips I. Infective endocarditis 1970-1979. A study of culture-positive cases in St. Thomas Hospital. Q J Med. 1980;49:315–28.
Mugge A, Daniel WG, Frank G, et al. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631–8.
Freedman LR, Valone J Jr. Experimental infective endocarditis. Prog Cardiovasc Dis. 1979;22:169–80.
Petersdorf RG, Pelletier LL, Durack DT. The 1976 Paul B. Beeson lecture. Some observations on experimental endocarditis. Yale J Biol Med. 1977;50:67–75.
Von Reyn CF, Levy BS, Arbeit RD, et al. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981;94:505–18.
Brandão TJD, Januario-da-Silva CA, Correia MG, Zappa M, Abrantes JA, Dantas AMR, Golebiovski W, Barbosa GIF, Weksler C, Lamas CC. Histopathology of valves in infective endocarditis, diagnostic criteria and treatment consideration. Infection. 2017;45:199–207.
Stone JR, Basso C, Baandrup UT, Bruneval P, Butany J, Gallagher PJ, Halushka MK, Miller DV, Padera RF, Radio SJ, Sheppard MN, Suvarna K, Tan CD, Thiene G, van der Wal AC, Veinot JP. Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology. Cardiovasc Pathol. 2012;21:2–16.
Ringer M, Feen DJ, Drapkin M. Mitral valve prolapse: jet stream causing mural endocarditis. Am J Cardiol. 1980;45:383–5.
Kuhn C III, Weber N. Mural bacterial endocarditis of a ventricular friction lesion. Arch Pathol. 1973;95:92–3.
Lucas RV Jr, Edwards JE. The floppy mitral valve. Curr Probl Cardiol. 1982;7:1–48.
Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1–142.
El-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients; pathogenesis, diagnosis and treatment. Oncologist. 2007;12:518–23.
Eiken PW, Edwards WD, Tazelaar HD, et al. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. Mayo Clin Proc. 2001;76:1204–12.
Kim H, Suzuki M, Lie J, et al. Non-bacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation (DIC). Arch Pathol Lab Med. 1977;101:65–8.
Olney B, Schattenberg T, Campbell J, et al. The consequences of the inconsequential: marantic (non-bacterial thrombotic) endocarditis. Am Heart J. 1979;98:513–22.
Hojnik M, George J, Ziporen L, et al. Heart valve involvement (Libman-Sacks Endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579–87.
Selzer A, Kohn KE. Natural history of mitral stenosis: a review. Circulation. 1972;45:878–90.
Abernathy WS, Willis PW III. Thromboembolic complications of rheumatic heart disease. Cardiovasc Clin. 1973;5:131–75.
Cabot RC. Facts on the Heart. Philadelphia, PA: W. B. Saunders Company; 1926.
Wood P. An appreciation of mitral stenosis, I: clinical features. Br Med J. 1954;4870:1051–63.
Rowe JC, Bland EF, Sprague HB, et al. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med. 1960;52:741–9.
Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J. 1962;24:349–57.
Rusted IE, Schiefley CH, Edwards JE. Studies of the mitral valve, II: certain anatomic features of the mitral valve and associated structures in mitral stenosis. Circulation. 1956;14:398–406.
Gorlin R, Gorlin SG. Hydraulic formula for calcification of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J. 1951;41:1–29.
Roberts WC. Morphologic features of the normal and abnormal mitral valve. Am J Cardiol. 1983;51:1005–28.
Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;91:1220–5.
Mohler ER III, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–8.
O’Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoproteins B (a), and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16:523–32.
Olsson M, Dalsgaard CJ, Haegerstrand A, et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23:1162–70.
Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol. 1987;59:998–9.
Mohler ER, Sheridan MJ, Nichols R, et al. Development and progression of aortic valve stenosis: atherosclerotic risk factors – a causal relationship? A clinical morphologic study. Clin Cardiol. 1991;14:995–9.
Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29:630–4.
Palta S, Pai AM, Gill KS, et al. New insights into the progression of aortic stenosis. Implications for secondary prevention. Circulation. 2000;101:2497–502.
Nassimiha D, Aronow WS, Ahn C. Association of coronary risk factors with progression of valvular aortic stenosis. Am J Cardiol. 2001;87:1313–4.
Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterisation of the early lesion of ‘degenerative’ valvular aortic stenosis; histological and immunohistochemical studies. Circulation. 1994;90:844–53.
Lindman BR, Clavel M-A, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.
Zhao Y, Nicoll R, He YH, Henein MY. The effects of statins on valve function and calcification in aortic stenosis: a meta-analysis. Atherosclerosis. 2016;246:318–24.
Kristen AV, Schnabel PA, Winter B, Helmke BM, Longerich T, Hardt S, Koch A, Sack F-U, Katus HA, Linke RP, Dengler TJ. High prevalence of amyloid in 150 surgically removed heart valves – a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovasc Pathol. 2010;19:228–35.
Audet A, Côté N, Couture C, Bossé Y, Després J-P, Pibarot P, Mathieu P. Amyloid substance within stenotic aortic valves promotes mineralization. Histopathology. 2012;61:610–9.
Kaden JJ, Dempfle CE, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodelling in calcific aortic valve stenosis. Cardiovasc Pathol. 2005;14:80–7.
Sprigings DC, Forfar JC. How should we manage symptomatic aortic stenosis in the patient who is 80 or older? Br Heart J. 1995;74:481–4.
Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(Suppl E):57–64.
Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–10.
Hein S, Arnon E, Kostin S, Schönberg M, Elsässer A, Polyakova V, Bauer EP, Klövekorn W-P, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart; structural deterioration and compensatory mechanisms. Circulation. 2003;107:984–91.
Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101–11.
Braverman AC, Guven H. Beardslee at al. The bicuspid aortic valve. Curr Probl Cardiol. 2005;30:470–522.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.
Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55:2789–800.
Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998;101:E11.
Lopez-Rangel E, Maurice M, McGillivray B, et al. Williams syndrome in adults. Am J Med Genet. 1992;44:720–9.
Roos-Hesselink JW, Scholzel BE, et al. Aortic valve and aortic arch pathology after coarctation repair. Heart. 2003;89:1074–7.
Deshpande J, Kinare SG. The bicuspid aortic valve – an autopsy study. Indian J Pathol Microbiol. 1991;34:112–8.
Suzuki T, Nagai R, Kurihara H, et al. Stenotic bicuspid aortic valve associated with a ventricular septal defect in an adult presenting with congestive heart failure: a rare observation. Eur Heart J. 1994;15:402–3.
Bolling SF, Iannattoni MD, Dick M II, et al. Shone’s anomaly: operative results and late outcome. Ann Thorac Surg. 1990;49:887–93.
Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270–4.
Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol. 1997;30:1809–12.
Cripe L, Andelfinger G, Martin J, et al. Bicuspid aortic valve is heritable. J Am Coll Cardiol. 2004;44:138–43.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008;52:e1–121.
Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26:72–83.
Fernandes SM, Khairy P, Sanders SP, et al. Bicuspid aortic valve morphology and interventions in the young. J Am Coll Cardiol. 2007;49:2211–4.
Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133:1226–33.
Sabet HY, Edwards WD, Tazelaar HD, et al. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc. 1999;74:14–26.
Angelini A, Ho SY, Anderson RH, et al. The morphology of the normal aortic valve as compared with the aortic valve having two cusps. J Thorac Cardiovasc Surg. 1989;89:362–7.
Beppu S, Suzuki S, Matsuda H, et al. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol. 1993;71:322–7.
Nigam V, Sievers HH, Jensen BC, Simpson PC, Srivastava D, Mohamed SA. Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves. J Heart Valve Dis. 2010;19:459–65.
Rajamannan NM. Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation. Cardiovasc Pathol. 2011;20:168–76.
Rabus MB, Kayalar N, Sareyyupoglu B, et al. Hypercholesterolaemia association with aortic stenosis of various etiologies. J Card Surg. 2009;24:146–50.
Yagubyan M, Sarkar G, Nishimura RA, et al. C-reactive protein as a marker of severe calcification among patients with bicuspid aortic valve disease. J Surg Res. 2004;121:281.
Fedak PW, Verma S, David TE, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation. 2002;106:900–4.
Pachulski RT, Weinberg AL, Chan KL. Aortic aneurysm in patients with functionally normal or minimally stenotic bicuspid aortic valve. Am J Cardiol. 1991;67:781–2.
Hahn RT, Roman MJ, Mogtader AH, et al. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol. 1992;19:283–8.
Edwards WD, Leaf DS, Edwards JE. Dissecting aortic aneurysm associated with congenital bicuspid aortic valve. Circulation. 1978;57:1022–5.
Roberts CS, Roberts WC. Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol. 1991;17:712–6.
Della Corte A, Bancone C, Quarto C, et al. Predictors of ascending aortic dilatation with bicuspid valve: a wide spectrum of disease expression. Eur J Cardiothrac Surg. 2007;31:397–405.
Nistri S, Sorbo MD, Marin M, et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart. 1999;82:19–22.
Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol. 1984;53:849–55.
Ergin MA, Spielvogel D, Apaydin A, et al. Surgical treatment of the descending dilated aorta: when and how? Ann Thorac Surg. 1999;67:1834–9.
Morgan-Hughes GJ, Roobottom CA, Owens PE, et al. Dilatation of the aorta in pure, severe, bicuspid aortic valve stenosis. Am Heart J. 2004;147:736–40.
McKusick VA. Association of congenital bicuspid aortic valve and Erdheim’s cystic medial necrosis. Lancet. 1972;1:1026–7.
Niwa K, Perfloff JK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation. 2001;103:393–400.
Bonderman D, Gharehbaghi-Schnell E, Wollenek G, et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation. 1999;99:2138–43.
Waters KM, Rooper LM, Guajardo A, Halushka MK. Histopathologic differences partially distinguish syndromic aortic diseases. Cardiovasc Pathol. 2017;30:6–11.
Grewal N, Franken R, Mulder BJM, Goumans M-J, Lindeman JHN, Jongbloed MRM, DeRuiter MC, Klautz RJM, Bogers AJJC, Poelmann RE, Gittenberger-de Groot AC. Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy? Heart Vessels. 2016;31:795–806.
Olson LJ, Subramanian R, Ackermann DM, et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc. 1987;62:22–34.
Waller BF, Morrow AG, Maron BJ, et al. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 1982;104:276–88.
Freed LA, Acierno JS Jr, Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003;72:1551–9.
Read RC, Thal AP, Wendt VE. Symptomatic valvular myxomatous transformation (the floppy valve syndrome). A possible forme fruste of the Marfan syndrome. Circulation. 1965;32:897–910.
Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med. 1999;341:1–7.
Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999;65:1242–51.
Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation. 2005;112:2022–30.
Kyndt F, Schott JJ, Trochu JN, et al. Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet. 1998;62:627–32.
Virmani R, Atkinson JB, Forman MB. The pathology of mitral valve prolapse. Herz. 1988;13:215–26.
Cole WG, Chan D, Hickey AJ, et al. Collagen composition of normal and myxomatous human mitral heart valves. Biochem J. 1984;219:451–60.
Tamura K, Fukuda Y, Ishizaki M, et al. Abnormalities in elastic fibres and other connective-tissue components of floppy mitral valve. Am Heart J. 1995;129:1149–58.
Olsen EG, Al-Rufaie HK. The floppy mitral valve: study on pathogenesis. Br Heart J. 1980;44:674–83.
Prunotto M, Primo Caimmi P, Bongiovanni M. Cellular pathology of mitral valve prolapse. Cardiovasc Pathol. 2010;19:e113–7.
Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunmaitre XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat M, Rosenthal N, Solis J, Schott J-J, Schwammenthal E, Slaugenhaupt SA, Song J-K, Yacoub MH. Mitral valve disease – morphology and mechanisms. Nat Rev Cardiol. 2015;12:689–710.
Fontana ME, Sparks EA, Boudoulas H, et al. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol. 1991;16:309–75.
Grigioni F, Averinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40:84–92.
Nalliah CJ, Mahajan R, Elliot AD, Haqqani H, Lau DH, Vohra JK, Morton JB, Semsarian C, Marwick T, Kalman JM, Sanders P. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart. 2019;105:144–51.
Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, Chiara Frigo A, Rigato I, Migliore F, Pilichou K, Bertaglia E, Cacciavillani F, Bauce B, Corrado D, Thiene G, Ilceto S. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556–66.
Frescura C, Angelini A, Daliento L, Thiene G. Morphological aspects of Ebstein’s anomaly in adults. Thorac Cardiovasc Surg. 2000;48:203–8.
Attenhofer Jost CH, Tan NY, Hassan A, Vargas ER, Hodge DO, Dearani JA, Connolly H, Asirvatham SJ, McLeod CJ. Sudden death in patients with Ebstein anomaly. Eur Heart J. 2018;39:1970–7.
Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation – part III. Clin Cardiol. 1995;18:225–30.
Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation – part I. Clin Cardiol. 1995;19:97–102.
Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation – Part II. Clin Cardiol. 1995;18:167–74.
Waller BF, Howard J, Fess S. Pathology of pulmonic valve stenosis and pure regurgitation. Clin Cardiol. 1995;18:45–50.
Altrichter PM, Olson LJ, Edwards WD, et al. Surgical pathology of the pulmonary valve: a study of 116 cases spanning 15 years. Mayo Clin Proc. 1989;64:1352–60.
Gujral DM, Lloyd G, Bhattacharyya S. Radiation induced valvular heart disease. Heart. 2016;102:269–76.
Nair V, Belanger EC, Veinot JP. Lysosomal storage disorders affecting the heart: a review. Cardiovasc Pathol. 2019;39:12–24.
Fesslová V, Corti P, Sersale G, Rovelli A, Russo P, Mannarino S, Butera G, Parini R. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young. 2009;19:170–8.
Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH. Cardiac valvular anomalies in Fabry disease: clinical, morphological, and biochemical studies. Circulation. 1976;54:818–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Preston, S.D. (2019). Valvular Heart Disease. In: Suvarna, S. (eds) Cardiac Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-24560-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-24560-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24559-7
Online ISBN: 978-3-030-24560-3
eBook Packages: MedicineMedicine (R0)